4<(E)-2-(Methoxycarbonyl)-1-propen-1-yl>phenol | 153773-39-8

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: 4<(E)-2-(Methoxycarbonyl)-1-propen-1-yl>phenol
• 英文别名: (E)-3-(4-hydroxyphenyl)-2-methyl acrylic acid methyl ester；methyl 3-(4-hydroxyphenyl)-2-methyl-2-propenoate；methyl 4-hydroxy-α-methylcinnamate；methyl (E)-3-(4-hydroxyphenyl)-2-methylprop-2-enoate
• CAS: 153773-39-8
• 化学式: C₁₁H₁₂O₃
• 分子量: 192.214
• InChiKey: CPKCCIUDOPJZSI-BQYQJAHWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4<(E)-2-(Methoxycarbonyl)-1-propen-1-yl>phenol 在 sodium hydroxide 、 potassium carbonate 作用下， 以 四氢呋喃 、 水 、 乙腈 为溶剂， 反应 4.0h， 生成 (E)-3-[4-(7-Chloro-quinoxalin-2-yloxy)-phenyl]-2-methyl-acrylic acid
  参考文献：
  名称：

  Synthetic modification of the 2-oxypropionic acid moiety in 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid (XK469), and consequent antitumor effects. Part 4

  摘要：

  The criteria for the activity of 2-{4-[(7-chloro-2 -quinoxalinyl)oxy]phenoxy}propionic acid (XK469) and 2-{4-[(7-bromo-2-quinolinyl)oxy]phenoxy} propionic acid (SH80) against transplanted tumors in mice established in previous studies, require a (7-halo-2-quinoxalinoxy)- or a (7-halo-2-quinolinoxyl)-residue, respectively, bridged via a 1,4-OC6H4O-linker to C-2 of propionic acid. The present work demonstrates that substitution of fluorine at the 3-position of the 1,4-OC6H4O-linker of XK469 leads to a 10-fold reduction in activity, whereas the corresponding 2-fluoro analog proved to be 100-fold less active than XK469. Moreover, the latter tolerated substitution of but a single, additional methyl group to the 2-position of the propionic acid moiety, that is, the isobutyric acid analog, without loss of significant in vivo activity. Indeed, an intact 2-oxypropionic acid moiety is a prerequisite for maximum antitumor activity of 1a. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2005.04.011
• 作为产物：
  描述：

  (E)-3-(4-hydroxyphenyl)-2-methylacrylic acid 在 硫酸 作用下， 以 甲醇 、 水 为溶剂， 生成 4<(E)-2-(Methoxycarbonyl)-1-propen-1-yl>phenol
  参考文献：
  名称：

  Phenylcarboxylic acid derivatives

  摘要：

  苯甲酸衍生物，具有以下通式：##STR1## 其中R1和R2各自为H、卤素、烷基、卤代烷基、烷酰基、环烷基、硝基、氨基、--O--D--R5（D为亚烷基，R5为H、氨基、吗啉基、羧基、邻苯二甲酰亚胺、苯基、环氧基）、取代或未取代的苯氧基、取代或未取代的苯基烷基氨基、羧基烯基，或两者共同形成亚烷基二氧；R3为H、--E--R6（E为亚烷基，R6为H、羧基、氰基、OH、苯基烷氧基、或卤素取代的苯基，或苯基氨基甲酰基）、--CO--G--R7（G为亚烷基，R7为H、取代或未取代的苯基氨基甲酰基）、取代或未取代的苯甲酰基、烯基、氨基甲酰基、苯基、或卤代苯基；R4为H或烷基；A为亚烷基、与环烷基环稠合的亚烷基，或亚烯基；B为亚烷基或亚烯基；l为0或1。这些化合物具有抑制脂肪酸合成、抑制胆固醇合成的作用，并可作为降脂剂、动脉粥样硬化的预防和治疗剂、肥胖的预防和治疗剂、抗糖尿病药物。

  公开号：

  US04999378A1

文献信息

• [EN] ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS<br/>[FR] DÉRIVÉS D'ALBICIDINE, LEUR UTILISATION ET LEUR SYNTHÈSE
  申请人：TECH UNIVERSITÄT BERLIN

  公开号：WO2014125075A1

  公开（公告）日：2014-08-21

  The present invention relates to a antibiotically active compounds characterized by general formula (I), wherein X1, BB, BC, BD, BE and X2 are building blocks with D1, D2, D3, D4 or D5 being linkers which comprise carbon, sulphur, nitrogen, phosphor and/or oxygen atoms and which are covalently connecting the moities BA and BB, BB and BC, BC and BD, BD and BE and BE and BF, respectively, and wherein in particular the building block BC comprises an amino acid derivative. The invention relates further to said compounds for use in a method of treatment of diseases, in particular for use in a method of treatment of bacterial infections.

  本发明涉及一种抗生素活性化合物，其特征在于一般式（I），其中X1、BB、BC、BD、BE和X2是具有D1、D2、D3、D4或D5为连接物的构建块，该连接物包括碳、硫、氮、磷和/或氧原子，并以共价键连接BA和BB、BB和BC、BC和BD、BD和BE以及BE和BF的基团，特别是构建块BC包括氨基酸衍生物。该发明还涉及上述化合物用于治疗疾病的方法，特别是用于治疗细菌感染的方法。
• Efficient Method for Aziridination of Olefines
  作者：Madhukar B. Hogale、Pravina B. Chavan

  DOI：10.1135/cccc19931705

  日期：——

  New method for aziridination of olefinic esters is described.

  新的烯丙基酯环氧胺化方法。
• A Versatile Catalyst for Heck Reactions of Aryl Chlorides and Aryl Bromides under Mild Conditions
  作者：Adam F. Littke、Gregory C. Fu

  DOI：10.1021/ja010988c

  日期：2001.7.1

  for Heck reactions of aryl chlorides and bromides. A sterically and electronically diverse array of aryl bromides, as well as activated aryl chlorides, couple with a range of mono- and disubstituted olefins at room temperature, furnishing the arylated product with high E/Z stereoselection. The corresponding reactions of a broad spectrum of electron-neutral and electron-rich aryl chlorides proceed at

  在 Cy2NMe 存在下，Pd/P(t-Bu)3 可作为一种非常温和且用途广泛的催化剂，用于芳基氯化物和溴化物的 Heck 反应。空间和电子上不同的芳基溴化物阵列以及活化的芳基氯化物，在室温下与一系列单取代和双取代的烯烃偶联，为芳基化产物提供高 E/Z 立体选择。广泛的电子中性和富电子芳基氯化物的相应反应在升高的温度下进行，并且具有高选择性。在范围和温和性方面，Pd/P(t-Bu)3/Cy2NMe 代表了先前报道的这些 Heck 偶联过程的催化剂的进步。
• A stereoselective route to the sugar-cinnamate unit of Hygromycin A
  作者：J.Grant Buchanan、David G. Hill、Richard H. Wightman、Ian K. Boddy、Brian D. Hewitt

  DOI：10.1016/0040-4020(95)00262-7

  日期：1995.5

  Various aryl 6-deoxy-5-keto-β-D-arabino-hexofuranosides, including one (42) corresponding to the sugar-cinnamate unit of Hygromycin A (1) have been synthesized by a method in which 6-deoxy-β-D-glucofuranosides are first prepared, followed by configurational inversion at positions 2 and 3 via 2,3-anhydro-6-deoxy-β-D-mannofuranosyl intermediates.

  通过其中6-脱氧-β-的方法合成了多种芳基6-脱氧-5-酮-β-D-阿拉伯-六呋喃糖苷，包括对应于潮霉素A（1）的糖-肉桂酸酯单元的一种（42）。首先制备D-葡萄糖呋喃糖苷，然后经由2，3-脱水-6-脱氧-β-D-甘露呋喃糖基中间体在位置2和3处构型转化。
• [EN] PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS<br/>[FR] PROCEDE DE PRODUCTION D'ACIDES 3-(4-HYDROXYPHENYL)PROPIONIQUES OPTIQUEMENT ACTIFS
  申请人：TAKASAGO PERFUMERY CO LTD

  公开号：WO2005051882A1

  公开（公告）日：2005-06-09

  The present invention relates to a process for producing an optically active 3-(4-hydroxyphenyl)propionic acid useful as intermediates for medicines, through short steps in good yield and with high optical purity. More specifically, the present invention relates to a process for producing an optically active 3-(4-hydroxyphenyl)propionic acid of the formula (6): wherein R2 is an alkyl group; R5 to R8 are each independently a hydrogen atom or a substituent; and the symbol * is an chiral carbon atom, or a salt thereof, which comprises reacting a benzaldehyde of the formula (1): wherein R1 is a protective group; and R5 to R8 are each the same as defined above, with a glycolic acid derivative of the formula (2): wherein R3 is a hydrocarbon group; and R2 is the same as defined above, hydrolyzing the resulting product to give a cinnamic acid of the formula (4): wherein R1, R2 and R5 to R8 are each the same as defined above, or a salt thereof, and subjecting the resulting cinnamic acid (4) or a salt thereof to asymmetric hydrogenation to give an optically active phenylpropionic acid of the formula (5): wherein all the symbols are each the same as defined above, or a salt thereof, followed by deprotection.

  本发明涉及一种生产光学活性3-(4-羟基苯基)丙酸的工艺，作为药物中间体，通过简短的步骤、高产率和高光学纯度。更具体地，本发明涉及一种生产光学活性3-(4-羟基苯基)丙酸的工艺，其化学结构如下（6）：其中R2是烷基；R5至R8分别独立地是氢原子或取代基；符号*是一个手性碳原子，或其盐，包括将化学结构如下（1）的苯甲醛：其中R1是保护基；R5至R8分别与上述定义相同，与化学结构如下（2）的甘醇酸衍生物反应：其中R3是烃基；R2与上述定义相同，水解得到肉桂酸的产物：其中R1、R2和R5至R8分别与上述定义相同，或其盐，并将得到的肉桂酸（4）或其盐进行不对称氢化反应，得到光学活性苯丙酸的产物：其中所有符号均与上述定义相同，或其盐，随后进行去保护处理。